Why #MEAction is Taking Action towards the CDC on Two Fronts

Share on facebook
Share on twitter
Share on email

#MEAction has announced two CDC-related advocacy actions today and yesterday. 

We are asking you to contact your Senators to increase research funding for ME through the Centers for Disease Control and Prevention (CDC), AND we have also published an open letter to the CDC calling them out for insufficient transparency and accountability in their regular stakeholder engagement calls with the ME community.

Since our inception, #MEAction has spoken out both about the inequity of funding allocation and the government’s failure to make ME a priority. We have consistently fought for increased research dollars, more informed clinicians, and meaningful stakeholder involvement in federal agency programs.

We simultaneously advocate for more funding for federal agencies to address our priorities, and work to hold those agencies accountable to the community and pressure them to do better.  We are are doing both of those things over the course of 24 hours! 

This dual approach is intentional. We need to work both within existing structures of federal agencies in order to achieve important goals like a nationwide epidemiological study, and at the same time hold them accountable to the community. We must always demand excellence. We know that there isn’t time to waste. People with ME deserve active, accountable federal agencies to provide treatments, quality care and, one day, a cure.

As we announce both of our CDC actions – a request to contact your Senators and a letter to the CDC – we know you care deeply about both things: obtaining increased research funding, and holding the CDC accountable for its actions towards the ME community.

We work within imperfect structures and institutions. Knowing that, we have to make effective strategic decisions so that people with ME get the care, treatment, and research they deserve.

We ask you to take the actions today, to help us get a step closer to equitable funding for ME research.

 

[maxbutton id=”17″ url=”https://act.meaction.net/page/11376/action/1?ea.tracking.id=web” text=”Contact your Senator” ]

 

[maxbutton id=”15″ url=” https://www.meaction.net/2019/06/05/we-need-effectiv…agement-from-cdc/” text=”Read our Letter to the CDC” ]

 

Share on facebook
Facebook
Share on twitter
Twitter
Share on whatsapp
WhatsApp
Share on google
Google+
Share on email
Email

Leave a Comment

Your email address will not be published. Required fields are marked *

Latest News

Sign petition To Fix ME/CFS tracking In US!

In August, we shared with you that we and six other ME/CFS organizations had submitted a proposal to the National Center of Health Statistics (NCHS) to fix the coding of ME/CFS in the US International Classification of Diseases (ICD-10-CM). Today, we are writing with an update on that proposal and asking that you sign the

Read More »

NICE announces roundtable event to ensure implementation of ME/CFS guideline

NICE announced today that it will hold a roundtable in September as the next step in the publication of the ME/CFS guideline. The roundtable will include representatives from patient organisations and charities, relevant professional societies, NHS England and NHS Improvement, NICE and the guideline committee. It aims to, “better understand the issues raised and determine

Read More »

#MEAction & 6 ME Orgs Call for CDC to Change How it Tracks ME/CFS

Together with six other organizations, we have submitted a proposal to the National Center for Health Statistics (NCHS) to add myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) to the neurological chapter of the International Classification of Diseases (ICD-10-CM).  Today, ME/CFS does not exist in the US ICD-10-CM. Instead,  most US doctors assign the code for chronic fatigue

Read More »

Help keep our work going

We rely on donations from people like you to keep fighting for equality for people with ME.

Donate

Get actions alerts and news direct to your inbox

You can choose what you want to be kept up to date on.

Subscribe
Scroll to Top